Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,872 | 170 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $511.22 | 26 | $0 (2023) |
| Abbott Laboratories | $319.59 | 17 | $0 (2024) |
| PFIZER INC. | $280.15 | 10 | $0 (2023) |
| Amgen Inc. | $257.63 | 13 | $0 (2023) |
| CONMED Corporation | $209.82 | 3 | $0 (2018) |
| ABBVIE INC. | $197.76 | 12 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $197.04 | 11 | $0 (2021) |
| Allergan, Inc. | $192.93 | 6 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $174.03 | 4 | $0 (2020) |
| Lilly USA, LLC | $173.43 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $309.46 | 12 | Abbott Laboratories ($121.27) |
| 2023 | $481.60 | 23 | Novo Nordisk Inc ($156.71) |
| 2022 | $421.58 | 24 | ABBVIE INC. ($75.15) |
| 2021 | $715.50 | 42 | Amgen Inc. ($165.40) |
| 2020 | $785.99 | 39 | Allergan, Inc. ($180.07) |
| 2019 | $203.18 | 13 | PFIZER INC. ($68.75) |
| 2018 | $768.80 | 14 | CONMED Corporation ($209.82) |
| 2017 | $185.41 | 3 | Boehringer Ingelheim Pharmaceuticals, Inc. ($144.70) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 7 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/13/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: VACCINES | ||||||
| 02/05/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: DERMATOLOGY | ||||||
| 01/10/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2018 | Medtronic Vascular, Inc. | Micra (Device) | Food and Beverage | In-kind items and services | $163.22 | General |
| Category: Pacemakers | ||||||
| 12/18/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/05/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/31/2018 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: Central Nervous System | ||||||
| 10/30/2018 | CONMED Corporation | AirSeal (Device) | Food and Beverage | In-kind items and services | $74.87 | General |
| Category: General Surgery | ||||||
| 10/10/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Diabetes | ||||||
| 10/08/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Gastroenterology | ||||||
| 09/12/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: HCV | ||||||
| 09/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes | ||||||
| 08/29/2018 | CONMED Corporation | AirSeal (Device) | Food and Beverage | In-kind items and services | $66.47 | General |
| Category: General Surgery | ||||||
| 08/01/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Gastroenterology | ||||||
| 06/27/2018 | CONMED Corporation | AirSeal (Device) | Food and Beverage | In-kind items and services | $68.48 | General |
| Category: General Surgery | ||||||
| 04/16/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: Immunology | ||||||
| 11/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $80.36 | General |
| 11/02/2017 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $40.71 | General |
| Category: Metabolism & Primary Care | ||||||
| 10/25/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $64.34 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,282 | 2,654 | $363,395 | $195,040 |
| 2022 | 15 | 1,322 | 2,563 | $350,650 | $180,930 |
| 2021 | 12 | 1,156 | 2,530 | $334,895 | $172,518 |
| 2020 | 15 | 1,271 | 2,868 | $373,606 | $194,293 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 277 | 1,099 | $120,890 | $67,599 | 55.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 238 | 347 | $41,660 | $32,098 | 77.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 159 | 203 | $50,750 | $27,228 | 53.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 208 | 264 | $63,360 | $26,779 | 42.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 193 | 415 | $41,500 | $16,243 | 39.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 118 | 162 | $24,230 | $14,420 | 59.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 23 | 63 | $8,820 | $5,163 | 58.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 18 | 38 | $4,950 | $2,188 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 18 | $2,475 | $1,379 | 55.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 17 | 17 | $2,380 | $1,064 | 44.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 28 | $2,380 | $879.62 | 37.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 261 | 981 | $107,920 | $54,647 | 50.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 205 | 276 | $66,240 | $29,368 | 44.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 143 | 186 | $46,540 | $28,845 | 62.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 179 | 281 | $33,770 | $22,472 | 66.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 139 | 185 | $27,740 | $15,097 | 54.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 183 | 332 | $33,230 | $10,173 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 101 | $13,635 | $9,339 | 68.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 17 | 47 | $6,390 | $3,307 | 51.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 16 | 29 | $3,640 | $1,555 | 42.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 23 | 38 | $3,230 | $1,521 | 47.1% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 22 | 24 | $2,200 | $1,465 | 66.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 20 | $1,900 | $1,432 | 75.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 20 | $2,820 | $1,123 | 39.8% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2022 | 18 | 22 | $1,185 | $524.85 | 44.3% |
About Dr. Sean Nochimson, D.O
Dr. Sean Nochimson, D.O is a Internal Medicine healthcare provider based in Lauderhill, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2015. The National Provider Identifier (NPI) number assigned to this provider is 1396124780.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Nochimson, D.O has received a total of $3,872 in payments from pharmaceutical and medical device companies, with $309.46 received in 2024. These payments were reported across 170 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,872).
As a Medicare-enrolled provider, Nochimson has provided services to 5,031 Medicare beneficiaries, totaling 10,615 services with total Medicare billing of $742,781. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lauderhill, FL
- Active Since 05/19/2015
- Last Updated 07/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396124780
Products in Payments
- UBRELVY (Drug) $303.59
- Ozempic (Drug) $293.97
- AirSeal (Device) $209.82
- XARELTO (Drug) $197.04
- Micra (Device) $163.22
- FREESTYLE LIBRE 3 (Device) $155.11
- Vascepa (Drug) $147.74
- Otezla (Drug) $143.42
- EUCRISA (Drug) $139.42
- FARXIGA (Drug) $132.84
- FREESTYLE LIBRE 2 (Device) $128.13
- Epclusa (Drug) $124.99
- Kerendia (Drug) $102.20
- JARDIANCE (Drug) $92.42
- Aimovig (Biological) $82.52
- XIFAXAN (Drug) $74.39
- Yupelri (Drug) $71.41
- MOUNJARO (Drug) $68.21
- TRELEGY ELLIPTA (Drug) $67.98
- EMGALITY (Drug) $47.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lauderhill
Dr. Ross Nochimson, M.d, M.D
Internal Medicine — Payments: $10,283
Dr. Jessica Geller, M.d, M.D
Internal Medicine — Payments: $990.36
Herbert Slavin, Md, MD
Internal Medicine — Payments: $717.60
Dr. Daniel Leon Roumain, M.d, M.D
Internal Medicine — Payments: $610.80
Dr. John Wolf, M.d, M.D
Internal Medicine — Payments: $189.45
Natasha Cedeno, M.d, M.D
Internal Medicine — Payments: $47.29